Watson-Marlow to highlight scalable peristaltic cased pump range and single-use assemblies at BioProcess International Europe 

• BioProcess International | Vienna, Austria | 27-30 April 2026. 
• Watson-Marlow to showcase fluid path components ideal for upstream, downstream and final fill/finish applications. 
• Visit stand 700 to learn how we can help your company accelerate regulatory compliance and elevate bioprocess performance. 

Falmouth, UK, 20th April 2026 / Sciad Communications / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its flexible and scalable fluid management solutions at BioProcess International Europe, Vienna, Austria, 27-30 April 2026. 

WMFTS fluid path technologies provide flow accuracy and ensure process stability, good manufacturing practice compliance and final product quality. The team will be on hand at BPI Europe to discuss your bioprocessing challenges and share how scalable peristaltic cased pumps and single-use assemblies can support unique processing demands throughout upstream, downstream and final fill/finish applications. 

Showcased products will include:  

• Watson-Marlow peristaltic cased pumps deliver accuracy of up to +/-0.5% to guarantee process stability and product quality, with a closed fluid path to assure complete isolation from any source of contamination during transfer, filling and filtration applications. The digitally controllable and compact pumps are easy to use with low maintenance, minimal pulsation and low shear pumping to protect cell integrity. 

• WMArchitect™ single-use solutions is designed to offer both standard, ready-to-use single-use assemblies as well as customised designs that are fully supported with tailored validation packages. WMArchitect will streamline a process, safeguard product, reduce regulatory burden and resolve challenges for end-to-end, single-use fluid path management. 

• Manufactured in ISO 14644-1 class 7 cleanrooms and rigorously tested, Watson-Marlow Tubing is available with internal diameters from 0.5 mm up to 25.4 mm ensuring high accuracy control of small flow rates as well the ability to handle larger flow rates as your bioprocess scales. 

Chris Palmer, WMFTS said: “Bioprocessing presents unique challenges throughout upstream, downstream and fill/finish. The demands of novel therapies require high precision fluid path components to protect product integrity, meet sterility requirements and ensure regulatory compliance. Watson-Marlow peristaltic pumps and fluid path components are designed specifically for biopharma applications, and our dedicated team collaborates with clients to customise solutions that will meet their specific needs. Stop by our booth to learn more about our comprehensive portfolio of products supported by in-depth industry expertise.”  

Visit the team at booth 700 to discuss your fluid management requirements and how Watson-Marlow can work with you to design the ideal solution for your bioprocessing needs. 

For more information about Watson-Marlow’s customised solutions for pharma and biotech, visit Pharmaceutical & Biotechnology | Life Sciences | WMFTS. 

ENDS

For further information, please contact:

Sciad Communications, Media Relations 

Jasmin Shearan 
E: watsonmarlow@sciad.com 
T: +44 (0)20 3405 7892 

Notes for Editors

About Watson-Marlow Fluid Technology Solutions 

Watson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in manufacturing peristaltic pumps and associated fluid path technologies for the life sciences and process industries. 

As a leading provider of peristaltic and sine pumps, automated filling machines, tubing, hoses, fluid path components and post-sales support technology, WMFTS partners with customers to solve challenges across various applications. 

WMFTS is a wholly owned subsidiary of Spirax Group, with operating units worldwide. 

Further information can be found at www.wmfts.com.